Cidara Therapeutics
Price & Volume
Stats
See moreOpen | $27.12 |
Previous Close | $26.81 |
Day Range | $26.35-$27.12 |
52W Range | $10.00-$28.42 |
Market Cap | $291.3M |
Shares Short | 36,101 |
Financials
See moreRevenue (12 Mos) | $53.8M |
Revenue Growth (YoY) | -94.1% |
Gross Profit (12 Mos) | -$11.2M |
Diluted EPS | -$23.90 |
News
See moreYahoo Finance • last year
Cidara Therapeutics to Present New Preclinical Data on Novel Dual-Acting Drug-Fc Conjugates at ESMO Immuno-Oncology Annual Congress
Yahoo Finance • last year
Cidara Therapeutics Named as a San Diego Metro Area Top Workplace
Yahoo Finance • last year
Cidara Therapeutics Presents Preclinical Data on Novel Drug-Fc Conjugate CBO421 at SITC’s 38ᵗʰ Annual Meeting
Yahoo Finance • last year
Cidara Therapeutics Provides Corporate Update and Reports Third Quarter 2023 Financial Results
About
CEO | Dr. Jeffrey L. Stein Ph.D. |
CFO | Dr. Preetam Shah M.B.A., Ph.D. |
Address | 6310 Nancy Ridge Drive, San Diego, CA, United States, 92121 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 69 |
